{"transactions":[{"id":3057007,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":147189,"kind":"person","name":"Ludwig Dale L.","position":1,"cik":"0001727406","reported_name":"Ludwig Dale L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T21:03:13.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested."}],"balance_after":50000,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-20-022314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390020022314/ownership.xml","form_type":"4"}},{"id":3460575,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":147189,"kind":"person","name":"Ludwig Dale L.","position":1,"cik":"0001727406","reported_name":"Ludwig Dale L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Options to purchase common stock","published_at":"2019-07-16T21:13:33.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":400000,"price":0.232,"value":92800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":0.232,"exercise_date":"2019-07-12","expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-19-012884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019012884/ownership.xml","form_type":"4"}},{"id":3756077,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":147189,"kind":"person","name":"Ludwig Dale L.","position":1,"cik":"0001727406","reported_name":"Ludwig Dale L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-11-20T22:08:00.000Z","date":"2018-11-19","kind":"purchase","acquired":true,"shares":10000,"price":0.4499,"value":4499.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-18-016321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018016321/ownership.xml","form_type":"4"}}]}